{"id":201,"date":"2020-11-18T01:10:16","date_gmt":"2020-11-18T01:10:16","guid":{"rendered":"https:\/\/kreklewetz.com\/gbmaware\/?p=201"},"modified":"2020-11-18T15:27:20","modified_gmt":"2020-11-18T15:27:20","slug":"nanomedicine-has-potential","status":"publish","type":"post","link":"https:\/\/www.kreklewetz.com\/gbmaware\/2020\/11\/18\/nanomedicine-has-potential\/","title":{"rendered":"Nanomedicine Has Potential"},"content":{"rendered":"\n<p>&#8220;Their study is the first to demonstrate an intravenous medication that can cross the blood-brain barrier. The discovery may one day lead to new clinical therapies for treating glioblastoma, and could lead to further therapies adopting their method for other \u201cundruggable\u201d tumors.&#8221;<\/p>\n\n\n\n<p><a href=\"https:\/\/www.genengnews.com\/news\/glioblastoma-nanomedicine-breaks-through-blood-brain-barrier-in-mice\/\" target=\"_blank\" rel=\"noreferrer noopener\">Read more<\/a> about how nanomedicine could be a potential treatment\/cure for GBMs.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>&#8220;Their study is the first to demonstrate an intravenous medication that can cross the blood-brain barrier. The discovery may one day lead to new clinical therapies for treating glioblastoma, and could lead to further therapies adopting their method for other \u201cundruggable\u201d tumors.&#8221; Read more about how nanomedicine could be a potential treatment\/cure for GBMs.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/www.kreklewetz.com\/gbmaware\/wp-json\/wp\/v2\/posts\/201"}],"collection":[{"href":"https:\/\/www.kreklewetz.com\/gbmaware\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.kreklewetz.com\/gbmaware\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.kreklewetz.com\/gbmaware\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.kreklewetz.com\/gbmaware\/wp-json\/wp\/v2\/comments?post=201"}],"version-history":[{"count":1,"href":"https:\/\/www.kreklewetz.com\/gbmaware\/wp-json\/wp\/v2\/posts\/201\/revisions"}],"predecessor-version":[{"id":202,"href":"https:\/\/www.kreklewetz.com\/gbmaware\/wp-json\/wp\/v2\/posts\/201\/revisions\/202"}],"wp:attachment":[{"href":"https:\/\/www.kreklewetz.com\/gbmaware\/wp-json\/wp\/v2\/media?parent=201"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.kreklewetz.com\/gbmaware\/wp-json\/wp\/v2\/categories?post=201"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.kreklewetz.com\/gbmaware\/wp-json\/wp\/v2\/tags?post=201"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}